Helius Medical Technologies Stock Today
| HSDT Stock | USD 0.40 0.03 6.98% |
PerformanceVery Weak
| Odds Of DistressVery High
|
Helius Medical is selling for under 0.4 as of the 24th of March 2025; that is 6.98% down since the beginning of the trading day. The stock's last reported lowest price was 0.39. Helius Medical has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 24th of December 2024 and ending today, the 24th of March 2025. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 27th of June 2014 | Category Healthcare | Classification Health Care |
Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. Its product, Portable Neuromodulation Stimulator , is a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company has 5.67 M outstanding shares of which 55.52 K shares are currently shorted by private and institutional investors with about 0.1 trading days to cover. More on Helius Medical Technologies
Moving together with Helius Stock
Moving against Helius Stock
Helius Stock Highlights
| CEO President | Dane Andreeff | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NASDAQ Composite, NASDAQ Health Care, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsHelius Medical can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Helius Medical's financial leverage. It provides some insight into what part of Helius Medical's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Helius Medical Technologies (HSDT) is traded on NASDAQ Exchange in USA. It is located in 642 Newtown Yardley Road, Newtown, PA, United States, 18940 and employs 22 people. Helius Medical is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 2.44 M. Helius Medical Techn conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 5.67 M outstanding shares of which 55.52 K shares are currently shorted by private and institutional investors with about 0.1 trading days to cover.
Helius Medical Technologies currently holds about 3.27 M in cash with (10.42 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.12.
Check Helius Medical Probability Of Bankruptcy
Ownership AllocationRoughly 92.85 (percent) of Helius Medical outstanding shares are held by general public with 0.52 % owned by insiders and only 6.63 pct. by outside corporations.
Check Helius Ownership Details
Helius Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Corecap Advisors, Llc | 2024-12-31 | 200 | |
| Fedenia Advisers Llc | 2024-12-31 | 100.0 | |
| Advisor Group Holdings, Inc. | 2024-12-31 | 80.0 | |
| Federation Des Caisses Desjardins Du Quebec | 2024-12-31 | 32.0 | |
| Bank Of America Corp | 2024-12-31 | 31.0 | |
| St Germain D J Co Inc | 2024-12-31 | 2.0 | |
| Susquehanna International Group, Llp | 2024-12-31 | 0.0 | |
| The Toronto-dominion Bank | 2024-09-30 | 0.0 | |
| Morgan Stanley - Brokerage Accounts | 2024-12-31 | 0.0 | |
| Virtu Financial Llc | 2024-12-31 | 46.5 K | |
| Grant Private Wealth Management Inc | 2024-12-31 | 37.2 K |
Helius Medical Historical Income Statement
Helius Stock Against Markets
Helius Medical Corporate Management
| Brian Bapty | VP of Strategy and Bus. Devel. | Profile | |
| CPA CPA | Treasurer, CFO | Profile | |
| Lawrence Picciano | Quality Engineering | Profile | |
| Antonella MD | Chief Officer | Profile |
Additional Tools for Helius Stock Analysis
When running Helius Medical's price analysis, check to measure Helius Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Helius Medical is operating at the current time. Most of Helius Medical's value examination focuses on studying past and present price action to predict the probability of Helius Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Helius Medical's price. Additionally, you may evaluate how the addition of Helius Medical to your portfolios can decrease your overall portfolio volatility.